TNYA
Tenaya Therapeutics, Inc.Company with tickers: TNYA
CIK
1858848
CUSIP
87990A106
Shares Outstanding
216,998,876
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-02-25 | COLUMN GROUP III GP, LP | 10% Owner | Sell | 1,649,281 |
| 2026-02-24 | COLUMN GROUP III GP, LP | 10% Owner | Other | 49,313,559 |
| 2026-02-24 | COLUMN GROUP III GP, LP | 10% Owner | Sell | 309,228 |
| 2026-02-23 | COLUMN GROUP III GP, LP | 10% Owner | Sell | 143,709 |
| 2026-02-20 | COLUMN GROUP III GP, LP | 10% Owner | Other | 49,313,559 |
| 2026-02-20 | COLUMN GROUP III GP, LP | 10% Owner | Sell | 245,965 |
| 2026-02-17 | Higa Tomohiro | SVP, Finance | Sell | 611 |
| 2026-02-17 | Ali Faraz | Director, Chief Executive Officer | Sell | 5,851 |
| 2026-02-17 | Tingley Whittemore | Chief Medical Officer | Sell | 1,642 |
| 2026-02-11 | COLUMN GROUP III GP, LP | 10% Owner | Sell | 1,905,115 |
| 2026-02-10 | COLUMN GROUP III GP, LP | 10% Owner | Sell | 161,422 |
| 2026-02-10 | COLUMN GROUP III GP, LP | 10% Owner | Other | 49,313,559 |
| 2026-02-03 | Higa Tomohiro | SVP, Finance | Award | 29,250 |
| 2026-02-03 | Higa Tomohiro | SVP, Finance | Award | 175,500 |
| 2026-02-03 | Tingley Whittemore | Chief Medical Officer | Award | 318,500 |
| 2026-02-03 | Tingley Whittemore | Chief Medical Officer | Award | 48,750 |
| 2026-02-03 | Ali Faraz | Director, Chief Executive Officer | Award | 158,600 |
| 2026-02-03 | Ali Faraz | Director, Chief Executive Officer | Award | 952,250 |
| 2025-11-17 | Higa Tomohiro | SVP, Finance | Sell | 1,367 |
| 2025-11-17 | Tingley Whittemore | Chief Medical Officer | Sell | 2,877 |
| 2025-11-17 | Ali Faraz | Director, Chief Executive Officer | Sell | 3,126 |
| 2025-08-18 | Higa Tomohiro | SVP, Finance | Sell | 523 |
| 2025-08-18 | Tingley Whittemore | Chief Medical Officer | Sell | 1,608 |
| 2025-08-18 | Ali Faraz | Director, Chief Executive Officer | Sell | 5,720 |
| 2025-05-29 | Stehman-Breen Catherine | Director | Award | 107,400 |
| 2025-05-29 | Walsh Jeffrey T. | Director | Award | 107,400 |
| 2025-05-29 | Burroughs Amy L. | Director | Award | 107,400 |
| 2025-05-29 | GOEDDEL DAVID V | Director, 10% Owner | Award | 107,400 |
| 2025-05-29 | Williams R Sanders | Director | Award | 107,400 |
| 2025-05-29 | Srivastava Deepak | Director | Award | 107,400 |
| 2025-05-29 | Lee June | Director | Award | 107,400 |
| 2025-05-29 | Parschauer Karah Herdman | Director | Award | 107,400 |
| 2025-05-16 | Higa Tomohiro | SVP, Finance | Sell | 1,390 |
| 2025-05-16 | Tingley Whittemore | Chief Medical Officer | Sell | 2,937 |
| 2025-05-16 | Ali Faraz | Director, Chief Executive Officer | Sell | 3,189 |
| 2025-03-10 | Higa Tomohiro | SVP, Finance | Sell | 1,017 |
| 2025-03-10 | Tingley Whittemore | Chief Medical Officer | Sell | 1,727 |
| 2025-03-10 | Ali Faraz | Director, Chief Executive Officer | Sell | 5,794 |
| 2025-03-05 | COLUMN GROUP III GP, LP | 10% Owner | Buy | 35,714,284 |
| 2025-03-05 | COLUMN GROUP III GP, LP | 10% Owner | Other | 4,414,720 |
| 2025-03-05 | COLUMN GROUP III GP, LP | 10% Owner | Buy | 35,714,284 |
| 2025-03-05 | COLUMN GROUP III GP, LP | 10% Owner | Buy | 17,857,142 |
| 2025-03-05 | GOEDDEL DAVID V | Director, 10% Owner | Buy | 35,714,284 |
| 2025-03-05 | GOEDDEL DAVID V | Director, 10% Owner | Other | 4,414,720 |
| 2025-03-05 | GOEDDEL DAVID V | Director, 10% Owner | Buy | 35,714,284 |
| 2025-03-05 | GOEDDEL DAVID V | Director, 10% Owner | Buy | 17,857,142 |
| 2025-02-06 | Ali Faraz | Director, Chief Executive Officer | Other | 353,271 |
| 2025-02-06 | Ali Faraz | Director, Chief Executive Officer | Award | 650,000 |
| 2025-02-06 | Ali Faraz | Director, Chief Executive Officer | Award | 107,500 |
| 2025-02-06 | Ali Faraz | Director, Chief Executive Officer | Award | 353,271 |
| 2025-02-06 | Higa Tomohiro | SVP, Finance | Other | 30,484 |
| 2025-02-06 | Higa Tomohiro | SVP, Finance | Other | 0 |
| 2025-01-24 | Tingley Whittemore | Chief Medical Officer | Other | 69,982 |
| 2025-01-24 | Tingley Whittemore | Chief Medical Officer | Award | 40,000 |
| 2025-01-24 | Tingley Whittemore | Chief Medical Officer | Award | 235,000 |
| 2025-01-24 | Tingley Whittemore | Chief Medical Officer | Award | 69,982 |
| 2024-11-18 | Saito Chihiro | SVP, Accounting and Fin. Ops. | Sell | 2,258 |
| 2024-10-18 | Stehman-Breen Catherine | Director | Award | 34,000 |
| 2024-10-18 | Parschauer Karah Herdman | Director | Award | 34,000 |
| 2024-10-18 | Lee June | Director | Award | 34,000 |
| 2024-10-18 | GOEDDEL DAVID V | Director, 10% Owner | Award | 34,000 |
| 2024-10-18 | Walsh Jeffrey T. | Director | Award | 34,000 |
| 2024-10-18 | Williams R Sanders | Director | Award | 34,000 |
| 2024-10-18 | Srivastava Deepak | Director | Award | 34,000 |
| 2024-10-18 | Burroughs Amy L. | Director | Award | 34,000 |
| 2024-08-16 | Tingley Whittemore | Chief Medical Officer | Sell | 5,803 |
| 2024-08-16 | Saito Chihiro | SVP, Accounting and Fin. Ops. | Sell | 902 |
| 2024-08-16 | Ali Faraz | Director, Chief Executive Officer | Sell | 5,802 |
| 2024-08-15 | Saito Chihiro | SVP, Accounting and Fin. Ops. | Award | 25,000 |
| 2024-08-14 | Saito Chihiro | SVP, Accounting and Fin. Ops. | Other | 7,832 |
| 2024-08-14 | Saito Chihiro | SVP, Accounting and Fin. Ops. | Other | 0 |
| 2024-03-05 | Hoey Timothy | Chief Scientific Officer | Sell | 3,300 |
| 2024-02-23 | Hoey Timothy | Chief Scientific Officer | Award | 12,500 |
| 2024-02-23 | Hoey Timothy | Chief Scientific Officer | Award | 75,000 |
| 2024-02-23 | Tingley Whittemore | Chief Medical Officer | Award | 215,000 |
| 2024-02-23 | Tingley Whittemore | Chief Medical Officer | Award | 35,000 |
| 2024-02-23 | PATTERSON LEONE D | EVP, Chief Bus & Fin Officer | Award | 205,000 |
| 2024-02-23 | PATTERSON LEONE D | EVP, Chief Bus & Fin Officer | Award | 35,000 |
| 2024-02-23 | Ali Faraz | Director, Chief Executive Officer | Award | 85,000 |
| 2024-02-23 | Ali Faraz | Director, Chief Executive Officer | Award | 505,000 |
| 2024-02-20 | Hoey Timothy | Chief Scientific Officer | Sell | 6,369 |
| 2024-02-16 | Tingley Whittemore | Chief Medical Officer | Sell | 6,500 |
| 2024-02-16 | Hoey Timothy | Chief Scientific Officer | Sell | 4,681 |
| 2024-02-16 | PATTERSON LEONE D | EVP, Chief Bus & Fin Officer | Sell | 5,201 |
| 2024-02-16 | Ali Faraz | Director, Chief Executive Officer | Sell | 6,358 |
| 2024-02-12 | COLUMN GROUP III GP, LP | 10% Owner | Other | 4,414,720 |
| 2024-02-12 | COLUMN GROUP III GP, LP | 10% Owner | Buy | 2,222,222 |
| 2024-02-12 | GOEDDEL DAVID V | Director, 10% Owner | Other | 4,414,720 |
| 2024-02-12 | GOEDDEL DAVID V | Director, 10% Owner | Buy | 2,222,222 |
| 2023-08-29 | Hoey Timothy | Chief Scientific Officer | Sell | 7,243 |
| 2023-08-16 | Tingley Whittemore | Chief Medical Officer | Sell | 5,563 |
| 2023-08-16 | PATTERSON LEONE D | EVP, Chief Bus & Fin Officer | Sell | 4,452 |
| 2023-08-16 | Hoey Timothy | Chief Scientific Officer | Sell | 4,007 |
| 2023-08-16 | Ali Faraz | Director, Chief Executive Officer | Sell | 5,563 |
| 2023-06-09 | Walsh Jeffrey T. | Director | Award | 29,532 |
| 2023-06-09 | Parschauer Karah Herdman | Director | Award | 29,532 |
| 2023-06-09 | GOEDDEL DAVID V | Director, 10% Owner | Award | 29,532 |
| 2023-06-09 | Srivastava Deepak | Director | Award | 29,532 |
| 2023-06-09 | Williams R Sanders | Director | Award | 29,532 |
| 2023-06-09 | Stehman-Breen Catherine | Director | Award | 29,532 |